Developments in Personalized Medicine and New Options in Breast Cancer Treatment

Developments in Personalized Medicine and New Options in Breast Cancer Treatment

In this era of personalized medicine the standard “one dose fits all” approach to cancer care has been ineffective leading to treatment failures. Personalized medicine is a new healthcare paradigm that allows physicians to choose treatment methodology optimally based on a person’s genetic or protein profiles. Our breast cancer panel is talking to Dr. Jame Abraham of Cleveland Clinic to learn about the developments in personalized medicine in breast cancer treatment. The panel will also discuss research in this field and new options available for breast cancer treatment.

 

Panelists

Live Talk on March 30, 2017, 5 p.m.   EST 8

CureTalks is an online Talk featuring a leading expert in conversation with a panel and the audience. The audience can ask questions from the panelists LIVE on the talk by dial-ing in. To hear the talk via phone or on-line, please add your email on the left; we will send you Live Talk access details. You can also write your questions in the Comments/Questions section below and your question maybe selected to be featured on the talk.

  30-03-2017 17:00 30-03-2017 23:59 Developments in Personalized Medicine and New Options in Breast Cancer Treatment <p style="line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;" dir="ltr"><span style="font-size: 11pt; font-family: Arial; color: #222222; vertical-align: baseline; white-space: pre-wrap;">In this era of personalized medicine the standard &ldquo;one dose fits all&rdquo; approach to cancer care has been ineffective leading to treatment failures. Personalized medicine is a new healthcare paradigm that allows physicians to choose treatment methodology optimally based on a person&rsquo;s genetic or protein profiles. Our breast cancer panel is talking to Dr. Jame Abraham of Cleveland Clinic to learn about the developments in personalized medicine in breast cancer treatment. The panel will also discuss research in this field and new options available for breast cancer treatment. </span></p> <p><span style="font-size: 11pt; font-family: Arial; color: #222222; vertical-align: baseline; white-space: pre-wrap;">&nbsp;</span></p> USA Curetalks priya@trialx.com false DD/MM/YYYY



  • Anonymous User March 7, 2017, 7:46 a.m.  US/Eastern

    Is tumor profiling compulsorily done for all patients? How much time and money does it cost to the patients?

  • Anonymous User March 7, 2017, 7:39 a.m.  US/Eastern

    How are personal characteristics like lifestyle factors etc. thought to help guide breast cancer treatment in future?

  • Anonymous User March 7, 2017, 6:49 a.m.  US/Eastern

    Could you please talk a little about breast cancer clinical trials that we need to keep track of.

  • Anonymous User March 7, 2017, 6:04 a.m.  US/Eastern

    I have peripheral neuropathy in my feet after chemo. Do you think low level laser therapy would help?

  • Anonymous User March 7, 2017, 6:03 a.m.  US/Eastern

    What is the latest available treatment for hormone receptor positive cancer?

  • Anonymous User March 7, 2017, 6:02 a.m.  US/Eastern

    what is most common type of breast cancer in women and what are the risk factors behind that type of cancer?

  • Anonymous User Feb. 27, 2017, 2:20 p.m.  US/Eastern

    rrmm treated with dara , pom , dex w ith little success Where does one go ? the Hiv drug in combination with IP . pom, dex?

  • Anonymous User Feb. 27, 2017, 2:17 p.m.  US/Eastern

    if one has RR MM after Dara , Pomalyst ,dex where does one go ?